Baker Bros. Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,912
| Closed | -$4.7M | – | 106 |
|
|
2018
Q2 | $4.7M | Sell |
2,912
-2,721
| -48% | -$4.39M | 0.04% | 77 |
|
|
2018
Q1 | $9.14M | Hold |
5,633
| – | – | 0.08% | 62 |
|
|
2017
Q4 | $9.46M | Hold |
5,633
| – | – | 0.08% | 59 |
|
|
2017
Q3 | $7.88M | Hold |
5,633
| – | – | 0.06% | 60 |
|
|
2017
Q2 | $6.29M | Buy |
5,633
+1,821
| +48% | +$2.03M | 0.06% | 60 |
|
|
2017
Q1 | $2.07M | Hold |
3,812
| – | – | 0.02% | 88 |
|
|
2016
Q4 | $2.33M | Hold |
3,812
| – | – | 0.02% | 89 |
|
|
2016
Q3 | $2.73M | Hold |
3,812
| – | – | 0.02% | 84 |
|
|
2016
Q2 | $2.77M | Buy |
+3,812
| New | +$2.77M | 0.03% | 85 |
|